Pharming Group N.V. (NL) – Pharming’s C1 inhibitor product potentially effective in reducing complications following transplantation
Pharming’s C1 inhibitor product potentially effective in reducing complications following transplantation Leiden, The Netherlands, February 17, 2010. Biotech company Pharming Group NV (“Pharming” or “the Company”) (NYSE Euronext: PHARM) announced today publication of preclinical evidence that...
